Fermi America (NASDAQ:FRMI) shares dropped nearly 15% in premarket trading after the company announced the pricing of an enlarged $375 million offering of 5.00% convertible senior notes due in 2031.
The financing, priced late on July 9, triggered a sharp sell-off in after-hours trading that continued into Friday’s premarket session.
Convertible Offering Raises Dilution Concerns
The notes are being sold to qualified institutional buyers under Rule 144A and carry an initial conversion price of approximately $9.52 per share.
Initial purchasers also have the option to buy an additional $56.25 million of notes, increasing the potential size of the offering to $431.25 million. The possibility of additional share dilution weighed heavily on investor sentiment, particularly given the company’s ongoing cash consumption.
Funding Plans Come Under Scrutiny
The capital raise follows a difficult first quarter in which Fermi reported a net loss of roughly $189 million, largely driven by non-cash share-based compensation expenses. The company also generated no revenue during the period, falling short of analyst expectations and prompting several research firms to lower their ratings in recent months.
Management said the proceeds from the convertible notes will support development of the gigawatt-scale Project Matador AI power campus in Amarillo, Texas. However, the financing has reinforced concerns about the scale of the investment required and the company’s future funding needs.
Stock Declines Despite Positive Market Backdrop
The broader market offered little explanation for the weakness. Both the S&P 500 and Nasdaq were trading higher, with the technology-focused Nasdaq gaining around 1.3%, indicating that the selling pressure on Fermi was driven primarily by company-specific developments.
Investor interest in AI infrastructure remains strong more broadly, supported by Barclays’ forecast that hyperscaler spending on artificial intelligence could exceed $1 trillion before reaching its peak in 2028. Even so, execution risks continue to overshadow Fermi’s longer-term growth opportunity.
The combination of increased dilution risk, continued cash burn, governance concerns and a share price already well below its 52-week high of $36.99 has weighed heavily on investor confidence.
With the convertible notes transaction expected to close on July 14, 2026, the shares traded around $6.25, moving closer to their 52-week low of $4.47.